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Letter to the Editor
INDUCTION OF TUMOURS AND BIFUNCTIONAL CROSSLINKING
METABOLITES OF NITROSAMINES
SM,-I have already suggested that
the metabolites involved in the carcinogenic
action of alkylnitrosamines are likely to
be derivatives which retain an alkyl-
nitrosamino- moiety, but have acquired an
additional functional group (e.g. a reactive
carbonyl), by oxidation of one of the alkyl
groups (Schoental, 1973).
This possibility has already received
some experimental support. The acetyl ester
of N-hydroxymethyl-N-methylnitrosamine,
synthesized by Wiessler (1974) has proved
to be about 3 times as toxic as dimethyl-
nitrosamine (DMN) and more effective as
a carcinogen. It induced intestinal tumours
in rats given a single dose, half of its LD50,
by i.p. injection (Rice et al., 1975). The
ester also proved to be a more potent
mutagen than DMN, especially as regards
the induction in Drosophila of the specific
bobbed mutations, which are considered to
be relevant to the carcinogenic action
(Fahmy, Fahmy and Wiessler, 1975; Fahmy
and Fahmy, 1975).
The acetyl ester of N-hydroxymethyl-N-
methylnitrosamine would be expected to
undergo hydrolysis in tissues, become oxi-
dized to the bifunctional formyl derivative,
which could crosslink macromolecules in
chromatin, andpossiblyform cyclic structures
resistant to enzymic degradation. During
attempted mitosis a cell containing chromo-
somes with the changed chromatin might
behave abnormally. Indeed, in tissues in
which tumours eventually develop, stickiness
ofchromosomes and abnormal mitotic figures
are often seen.
Oxidation of an alkyl group with reten-
tion of an alkylnitrosamino- moiety is
known to occur in the case of the higher
homologues of DMN in which the alkyl is
ethyl, propyl, butyl, etc. (Okada and Suzuki,
1972; Blattmann and Preussmann, 1973,
1974, 1975; Blattmann, Joswig and Preuss-
mann, 1974). A number of the respective
omega and beta oxidation products have been
identified as rat urinary metabolites of the
parent alkylnitrosamines; some of the meta-
bolites had their alkyl chains shortened by
decarboxylation, etc. Retention of carcino-
genicactivitybyanumberofsuchmetabolites
has beenreported (e.g. Okada and Hashimoto,
1974). Some of the metabolites with the
shortened alkyl chains and/orcarbonyl groups
appeartohave increased carcinogenic efficacy
andtoinduce tumoursintissuesdifferentfrom
those affected by the parent substance.
The metabolic formation of potentially
bifunctional derivatives has been suggested
also in the case of a variety of other carcino-
gens (Schoental, 1974, 1976b). The distri-
bution of the two (not necessarily identical)
functional groups in these putative " acti-
vated " intermediates would be very similar.
Despite the variety of the chemical struc-
tures of the parent molecules, metabolic
oxidation of their most likely sites would
endow them with the possibility ofinteracting
with similar, or even the same, apposite
nucleophilic cellular receptor groups. The
respective receptor groups probably become
only temporarily exposed, at some particular
phase of the cell's existence-so that a
possibility of concerted action of both func-
tional groups and the formation of stable,
possibly cyclic, structures might be a rare
cellular occurrence.
It is of interest that N-acetoxy-2-
acetylaminofluorene has recently been re-
ported to crosslink in chromatin certain
'uncovered" parts of DNA with H4 and
H2A histones more effectively than other
parts (Metzger and Daune, 1975).
There is a possible dichotomy in the
action of the carcinogenic alkylnitrosamines.
Their acute and subacute effects appear to
be due to the depletion of coenzymes by
alkylating entities while in the induction
of tumours (Schoental, 1975a, b, 1976a),
bifunctional metabolic species may be in-
volved, able to crosslink marcomolecular
constituents of chromatin. Similar con-
sideration, would obviously apply also to
other types of carcinogens.LETTER TO THE EDITOR 669
It would be of particular interest to
investigate the tissue and intracellular dis-
tribution of the enzyme systems responsible
for the various metabolic pathways, and for
the formation of the various metabolic
species from the parent carcinogens. Certain
nutritional factors are already known to
be able to modify the response to carcino-
genic agents. Further exploration of such
factors might provide leads for the under-
standing of the mechanism of carcinogenesis
and hopefully provide clues on how to delay
or prevent the induction of tumours.
R. SCHOENTAL,
Department of Pathology,
Royal Veterinary College,
University of London,
London, NW1 OTU.
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